Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Pharmacodynamic evaluation of the etonogestrel contraceptive implant initiated midcycle with and without ulipristal acetate: An exploratory study

Contraception(2024)10.1016/j.contraception.2024.110370Source: DataRank Database

Pharmacodynamic evaluation of the etonogestrel contraceptive implant initiated midcycle with and without ulipristal acetate: An exploratory study is a research paper published in Contraception (2024). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)Impact (FWCI 0.40)OA: greenTopics (38)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Jennifer E. Kaiser ORCID,Alexandra Gero ORCID,Jessica N. Sanders ORCID,Erica Johnstone ORCID,David K. Turok ORCID

Live enrichment

PubMed:38232940 PMC:PMC10922844 OpenAlex:https://openalex.org/W4390988740

National Center for Advancing Translational Sciences

Grant: UL1TR002538

National Institutes of Health

Grant: 1TR001067

National Institutes of Health

Grant: K24HD087436

Agency for Healthcare Research and Quality

Grant: K01HS02722

NCATS NIH HHS

Grant: UL1 TR001067

NCATS NIH HHS

Grant: UM1 TR004409

Office of Research on Women's Health

State of Utah

Eunice Kennedy Shriver National Institute of Child Health and Human Development

Organon Inc

FWCI

0.40

Citation Percentile

0.6%

Influential Citations

Citation Trend

2024

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10922844/pdf/nihms-1960894.pdf

publisherhttps://api.elsevier.com/content/article/PII:S001078242400009X?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S001078242400009X?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10922844

Fields of Study

Reproductive Health and ContraceptionOvarian function and disordersMenstrual Health and DisordersMedicineFemaleHumansAdolescentYoung AdultAdultDesogestrelContraceptive Agents, FemaleContraception, PostcoitalNorpregnadienes

MeSH Terms

AdolescentAdultContraceptive Agents, FemaleFemaleHumansNorpregnadienesDesogestrelContraception, PostcoitalYoung Adult

Keywords

EtonogestrelUlipristal acetateMedicineContraceptive implantOvulationFollicular phaseEmergency contraceptionLevonorgestrelPopulationGynecologyRandomized controlled trialInternal medicineHormoneFamily planningPharmacodynamicsEtonogestrel Implant

Sustainable Development Goals

SDG 0: Good health and well-being

Pharmacodynamic evaluation of the etonogestrel contraceptive implant initiated midcycle with and without ulipristal acetate: An exploratory study

FAIR Checklist

Authors (6)

Funding (10 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)